Skip to main content
Veterinary Medicines

Versican Plus DHPPi (--) - Lyophilisate and solvent for suspension for injection

Authorised
  • Canine distemper virus, strain CDV Bio 11/A, Live
  • Canine adenovirus 2, strain CAV-2-Bio 13, Live
  • Canine parvovirus, type 2b, strain CPV-2b Bio 12/B, Live
  • Canine parainfluenza virus, strain CPiV-2-Bio 15, Live

Product identification

Medicine name:
Versican Plus DHPPi (--) - Lyophilisate and solvent for suspension for injection
Active substance:
  • Canine distemper virus, strain CDV Bio 11/A, Live
  • Canine adenovirus 2, strain CAV-2-Bio 13, Live
  • Canine parvovirus, type 2b, strain CPV-2b Bio 12/B, Live
  • Canine parainfluenza virus, strain CPiV-2-Bio 15, Live
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Canine distemper virus, strain CDV Bio 11/A, Live
    Presentation_strength:10³·¹ - 10⁵·¹ TCID₅₀ Reference:Ph Eur 0447 Comments:Lyophilisate Index:0
  • Canine adenovirus 2, strain CAV-2-Bio 13, Live
    Presentation_strength:10³·⁶ - 10⁵·³ TCID₅₀ Reference:Ph Eur 0447 Comments:Lyophilisate Index:1
  • Canine parvovirus, type 2b, strain CPV-2b Bio 12/B, Live
    Presentation_strength:10⁴·³ - 10⁶·⁶ TCID₅₀ Reference:Ph Eur 0447 Comments:Lyophilisate Index:2
  • Canine parainfluenza virus, strain CPiV-2-Bio 15, Live
    Presentation_strength:10³·¹ - 10⁵·¹ TCID₅₀ Reference:Ph Eur 0447 Comments:Lyophilisate Index:3
Pharmaceutical form:
  • Lyophilisate and solvent for suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AD04
Authorisation status:
  • Valid
Authorised in:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Malta
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)
Available in:
  • Belgium
  • Cyprus
  • Czechia
  • Denmark
  • Finland
  • Greece
  • Italy
  • Luxembourg
  • Netherlands
  • Poland
  • Slovakia
  • Spain
  • Sweden
Package description:
  • Packaging:Lyophilisate: vial (glass); solvent: vial (glass), Package_size:Lyophilisate: 50 vials + solvent: 50 vials, Content:Lyophilisate: 1 dose; solvent: 1 ml
  • Packaging:Lyophilisate: vial (glass); solvent: vial (glass), Package_size:Lyophiliate: 25 vials + solvent: 25 vials, Content:Lyophilisate: 1 dose; solvent: 1 ml

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Zoetis Belgium
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bioveta a.s.
Responsible authority:
  • European Commission
Authorisation number:
This information is not available for this product.
Date of authorisation status change:

Documents

Combined File of all Documents

English (PDF)
Published on: 5/03/2025
Download
Bulgarian (PDF)
Published on: 5/03/2025
Croatian (PDF)
Published on: 5/03/2025
Czech (PDF)
Published on: 5/03/2025
Danish (PDF)
Published on: 5/03/2025
Dutch (PDF)
Published on: 5/03/2025
Estonian (PDF)
Published on: 5/03/2025
Finnish (PDF)
Published on: 5/03/2025
French (PDF)
Published on: 5/03/2025
German (PDF)
Published on: 5/03/2025
Greek (PDF)
Published on: 5/03/2025
Hungarian (PDF)
Published on: 5/03/2025
Icelandic (PDF)
Published on: 5/03/2025
Italian (PDF)
Published on: 5/03/2025
Latvian (PDF)
Published on: 5/03/2025
Lithuanian (PDF)
Published on: 5/03/2025
Maltese (PDF)
Published on: 5/03/2025
Norwegian (PDF)
Published on: 5/03/2025
Polish (PDF)
Published on: 5/03/2025
Portuguese (PDF)
Published on: 5/03/2025
Romanian (PDF)
Published on: 5/03/2025
Slovak (PDF)
Published on: 5/03/2025
Slovenian (PDF)
Published on: 5/03/2025
Spanish (PDF)
Published on: 5/03/2025
Swedish (PDF)
Published on: 5/03/2025

ema-puar-versican-plus-dhppi-v-3679-par-en.pdf

English (PDF)
Published on: 16/03/2023
Download